First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGSBased MRD Analysis from the Phase 3 GAIA/CLL13 Trial
Moritz Fuerstenau,Matthias Ritgen,Sandra Robrecht,Julia Von Tresckow,Can Zhang,Anke Schilhabel,Michael Gregor,Patrick Thornton,Philipp Bernhard Staber,Tamar Tadmor,Vesa Lindstroem,Gunnar Juliusson,Ann Janssens,Mark-David Levin,Caspar Da Cunha-Bang,Christof Schneider,Neta Goldschmidt,Elisabeth Vandenberghe,Davide Rossi, Rudolf A. Benz,Daniel Heintel,Christian Bjorn Poulsen,Ilse Christiansen,Henrik Frederiksen,Lisbeth Enggaard,Eduardus Posthuma,Djamila Issa, Hein Visser,Mar Bellido,Nadine Kutsch,Jan Duerig, Alexander Stehle,Matthias C. Voehringer,Sebastian Boettcher,Clemens Schulte,Florian Simon,Anna-Maria Fink, Kirsten Fischer, Emily Holmes,Karl-Anton Kreuzer,Monika Brueggemann,Eugen Tausch,Stephan Stilgenbauer,Michael Hallek,Arnon P. Kater,Carsten Utoft Niemann, Barbara F. Eichhorst BLOOD(2023)
AI 理解论文
溯源树
样例